Viewing Study NCT05829356

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 11:35 PM

Ignite Modification Date: 2025-12-25 @ 9:24 PM

Study NCT ID: NCT05829356

Status: COMPLETED

Last Update Posted: 2025-09-12

First Post: 2023-04-06

Is NOT Gene Therapy: False

Has Adverse Events: False

Brief Title: Substudy 01 - Safety and Immunogenicity of One Monovalent Modified mRNA Vaccine Encoding Influenza Hemagglutinin With LNP, in Adult Participants Aged 18 to 49 Years and 60 Years and Above

Sponsor: Sanofi Pasteur, a Sanofi Company

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module